FOXO3 and neoplasm: It underlines a gene-dosage-dependent FOXO3 effect in vivo: Slightly increased activity induces tumor-angiogenesis and vessel permeability, whereas strong activation of over-expressed FOXO3 exposes the “FOXO3 tumor suppressor phenotype”.